A pharmaceutical company that announced a $100 million purchase of Litecoin (LTC) for its treasury.
AI-generated insights about MEI Pharma from various financial sources
The company's decision to purchase $100 million of Litecoin for its treasury was met with skepticism, questioning the strategic value of choosing LTC over other assets.
The company's decision to purchase $100 million of Litecoin for its treasury was met with skepticism, questioning the strategic value of choosing LTC over other assets.